-
Published05/05/2025
-
Deadline04/06/2025
-
Opening of tenders04/06/2025
-
Today23/06/2025
Utilities
- indicates text translated automatically in your browsing language
"Supply of the medicinal product Jardiance 10 mg, for a project financed by the Medical Research Agency, Poland, Project No 2020/ABM/01/00001, entitled: ‘Administration of empagliflozin in patients with hypertrophic cardiomyopathy’ and study support for repackaging, labelling, placebo formulation, site delivery and disposal of the investigational medicinal product and placebo.’ Text automatically translated in your browsing language Automatically translated
"Supply of the medicinal product Jardiance 10 mg, for a project financed by the Medical Research Agency, Poland, Project No 2020/ABM/01/00001, entitled: ‘Application of empagliflozin in patients with hypertrophic cardiomyopathy’ and study support for repackaging, labelling, placebo formulation, site delivery and disposal of the investigational medicinal product and placebo’ Text automatically translated in your browsing language Automatically translated
https://ikard.ezamawiajacy.pl/pn/ikard/demand/207796/notice/public/details
https://ikard.ezamawiajacy.pl/pn/ikard/demand/207796/notice/public/details
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.